Germany is the bigger Artificial Intelligence (AI) in Drugs Discovery market: $22 Mn against $16 Mn in 2023, about 1.4 times as large.
Germany grows faster: 24.3% a year, against 24.1%.
Clinical research: 18 active trials in the UK, 23 in Germany.
| Measure |  UK |  Germany |
|---|---|---|
| Market size, 2023 | $16 Mn | $22 Mn |
| Market size, 2033 projected | $135 Mn | $193 Mn |
| Growth a year (CAGR) | 24.1% | 24.3% |
| Money added, 2023–2033 | $120 Mn | $171 Mn |
| Share of the world market | 2.6% | 3.7% |
| Size rank of 24 countries | #7 | #5 |
| Market per person, 2023 | $0.22 | $0.26 |
| Active clinical trials | 18 | 23 |
| Full report | UK report | Germany report |
Year by year, 2023 to 2033
UK Germany · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Artificial Intelligence (AI) in Drugs Discovery, UK or Germany?
Germany is the bigger Artificial Intelligence (AI) in Drugs Discovery market: $22 Mn against $16 Mn in 2023, about 1.4 times as large.
Which grows faster in Artificial Intelligence (AI) in Drugs Discovery, UK or Germany?
Germany grows faster: 24.3% a year, against 24.1%.
More Artificial Intelligence (AI) in Drugs Discovery comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.